Drug Pipeline

Albumin-bound Paclitaxel Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
4
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT06743126
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated…		 Trial sites expanded: 59 -> 66 locations
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06743126 SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated… Melanoma, Cutaneous Malignant Recruiting
Phase 2
NCT07346807 Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced… Tongue Squamous Cell Carcinoma Not Yet Recruiting
Phase 1/2
NCT06771622 Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With… Solid Cancer Active, Not Recruiting
Not specified
NCT07389876 Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or… Gastric Cancer Recruiting
Sponsors Running Albumin-bound Paclitaxel Trials
Immatics US, Inc. (1) FBD Biologics Limited (1) Shanghai Zhongshan Hospital (1) Fudan University (1)
Disease Areas
Melanoma (1) Gastric Cancer (1)
Get alerts when Albumin-bound Paclitaxel trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free